Phage therapy of purulent-inflammatory pathology of the outer and middle ear

Gurov A.V.; Lapenko E.G.; Kryukov A.I.

doi:https://doi.org/10.17116/otorino20228704156

Close metadata

Recommended articles:

Clinical efficiency of polyvalent piobacteriophage in the complex treatment of nosocomial sinusitis. Russian Bulletin of Otorhinolaryngology. 2025;(4):33-38

Phage therapy analysis of effectiveness in comorbid patients with wounds and surgical infections of various etiology based on the results of a comparative clinical study. Pirogov Russian Journal of Surgery. 2025;(3):124-138

Clinical case of disturbance of the gut microbiota due to the use of braces-system. Russian Journal of Stomatology. 2025;(1):36-39

Biological and genomic characterisation of phage Ec2-7 with antimicrobial activity against STEC strains Escherichia coli. Molecular Genetics, Microbiology and Virology. 2025;(3):31-35

Abstract:

The steady growth of antibiotic resistance of bacteria and, as a result, difficulties in selecting effective drugs determine the search for an alternative strategy for the use of antimicrobials, and therapy based on the use of bacteriophages is such. Phage therapy in otorhinolaryngology is actively used for the treatment of rhinosinusitis, diseases of the pharynx and larynx. However, it should be noted that the use of this group of drugs in the treatment of ear diseases is not sufficiently covered. Currently, institutes and clinics around the world are undergoing many large multicenter studies aimed not only at finding effective bacteriophages against antibiotic-resistant bacteria, but also at isolating their enzymes (lysines), expression of transport proteins, genetic modifications that lead to the restoration of the sensitivity of bacteria to antimicrobial drugs. In this review, we sought to highlight modern works concerning the treatment of inflammatory ear diseases with bacteriophage preparations, the results of microbiological studies conducted in vitro, the main purpose of which was to combat multi-resistant strains of microorganisms — pathogens of purulent-inflammatory diseases of the outer and middle ear.

Keywords:

phage therapy

bacteriophages

otitis

Authors:

Gurov A.V.

N.I. Pirogov Russian National Research Medical University of the Ministry of Health of Russia;
Sverzhevsky Research Institute of Clinical Otorhinolaryngology

ORCID: 0000-0001-9811-8397

Lapenko E.G.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology

Kryukov A.I.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology;
Pirogov Russian National Research Medical University

ORCID: 0000-0002-0149-0676

Received:

14.10.2021

Accepted:

08.02.2022

Close metadata

References:

Palchun VT, Gurov AV. Focal infection and septic conditions in otorhinolaryngological practice. Vestnik otorinolaringologii. 2009;6:63-68. (In Russ.).
Kryukov AI, Gurov AV, Izotova GN, Luchsheva YV, Shadrin GB, Kravchuk AP. Furuncular otitis externa: differential diagnosis and treatment approaches. Medical Council. 2015;3:60-64. (In Russ.). https://doi.org/10.21518/2079-701X-2015-3-60-64
Kryukov AI, Garov EV, Krechetov GM, Zakharova AF. Incidence of chronic purulent otitis media and treatment of patients with this pathology in Moscow. Vestnik otorinolaringologii. 2010;6:31-33. (In Russ.).
Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study. The Lancet. Infectious Diseases. 2010;10(9):597-602. https://doi.org/10.1016/S1473-3099(10)70143-2
Czaplewski L, Bax R, Clokie M, Dawson M, Fairhead H, Fischetti VA, Foster S, Gilmore BF, Hancock RE, Harper D, Henderson IR, Hilpert K, Jones BV, Kadioglu A, Knowles D, Ólafsdóttir S, Payne D, Projan S, Shaunak S, Silverman J, Thomas CM, Trust TJ, Warn P, Rex JH. Alternatives to antibiotics-a pipeline portfolio review. The Lancet. Infectious Diseases. 2016;16(2):239-251. https://doi.org/10.1016/S1473-3099(15)00466-1
Stratieva OV. Ispol’zovanie polivalentnogo kombinirovannogo piobakteriofaga pri ostrykh i retsidiviruyushchikh paranazal’nykh sinusitakh u detej. Sb. trudov. XV s”ezd otorinolaringologov Rossii. SPb; 1995;2:32-35. (In Russ.).
Kryukov AI, Gurov AV, Izotova GN, Lapenko EG. The results of an observational (non-interventional) study “Analysis of the therapeutic efficacy of the drug piobacteriophage polyvalent (Sextaphage) in the treatment of acute purulent sinusitis”. Vestnik otorinolaringologii. 2019;84(5):55-60. (In Russ.). https://doi.org/10.17116/otorino20198405155
Sultanov NM. Antibakterial’naya aktivnost’ i klinicheskaya effektivnost’ preparata piobakteriofaga polivalentnogo ochishchennogo pri lechenii khronicheskogo gnojnogo rinosinusita: Diss. ... kand. biol. nauk. Ufa; 2007. (In Russ.).
Yanborisova ER, Yanborisov TM. The effect of piobacteriophage on mucociliary clearance when applied topically in children with acute sinusitis. Rossijskaya rinologiya. 1997;2:55. (In Russ.).
Ayzenshtadt AA, Sadovnikova IV. The use of bacteriophages in the treatment of diseases of ENT organs in children. Voprosy prakticheskoj pediatrii. 2018;13(2):49-53. (In Russ.). https://doi.org/10.20953/1817-7646-2018-2-49-53
Ferry T, Leboucher G, Fevre C, Herry Y, Conrad A, Josse J, Batailler C, Chidiac C, Medina M, Lustig S, Laurent F; Lyon BJI Study Group. Salvage Debridement, Antibiotics and Implant Retention (“DAIR”) With Local Injection of a Selected Cocktail of Bacteriophages: Is It an Option for an Elderly Patient with Relapsing Staphylococcus aureus Prosthetic-Joint Infection? Open Forum Infectious Diseases. 2018;5(11):ofy269. https://doi.org/10.1093/ofid/ofy269
Takemura-Uchiyama I, Uchiyama J, Osanai M, Morimoto N, Asagiri T, Ujihara T, Daibata M, Sugiura T, Matsuzaki S. Experimental phage therapy against lethal lungderived septicemia caused by Staphylococcus aureus in mice. Microbes and Infection. 2014;16(6):512-517. https://doi.org/10.1016/j.micinf.2014.02.011
Debarbieux L, Pirnay JP, Verbeken G, De Vos D, Merabishvili M, Huys I, Patey O, Schoonjans D, Vaneechoutte M, Zizi M, Rohde C. A bacteriophage journey at the European Medicines Agency. FEMS Microbiology Letters. 2016;363(2):fnv225. https://doi.org/10.1093/femsle/fnv225
Gordillo Altamirano F, Forsyth JH, Patwa R, Kostoulias X, Trim M, Subedi D, Archer SK, Morris FC, Oliveira C, Kielty L, Korneev D, O’Bryan MK, Lithgow TJ, Peleg AY, Barr JJ. Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials. Nature Microbiology. 2021;6(2):157-161. https://doi.org/10.1038/s41564-020-00830-7
Totté JEE, van Doorn MB, Pasmans S. Successful treatment of chronic Staphylococcus aureus-related dermatoses with the topical endolysin Staphefekt SA.100: A report of 3 cases. Case Reports in Dermatology. 2017;9(2):19-25. https://doi.org/10.1159/000473872
Rashel M, Uchiyama J, Ujihara T, Uehara Y, Kuramoto S, Sugihara S, Yagyu K, Muraoka A, Sugai M, Hiramatsu K, Honke K, Matsuzaki S. Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage ϕMR11. The Journal of Infectious Diseases. 2007;196(8):1237-1247. https://doi.org/10.1086/521305
Daniel A, Euler C, Collin M, Chahales P, Gorelick KJ, Fischetti VA. Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 2010;54(4):1603-1612. https://doi.org/10.1128/AAC.01625-09
Letrado P, Corsini B, Díez-Martínez R, Bustamante N, Yuste JE, García P. Bactericidal synergism between antibiotics and phage endolysin Cpl-711 to kill multidrug-resistant pneumococcus. Future Microbiology. 2018;13(11):1215-1223. https://doi.org/10.2217/fmb-2018-0077
Chhibber S, Kaur J, Kaur S. Liposome Entrapment of Bacteriophages Improves Wound Healing in a Diabetic Mouse MRSA Infection. Frontiers in Microbiology. 2018;9:561. https://doi.org/10.3389/fmicb.2018.00561
Chandler JR. Malignant external otitis: further considerations. The Annals of Otology, Rhinology, and Laryngology. 1977;86(4 Pt 1): 417-428. https://doi.org/10.1177%2F000348947708600401
Hasibi M, Ashtiani MK, Motassadi Zarandi M, Yazdani N, Borghei P, Kuhi A, Dabiri S, Hosseini R, Sardashti S. A Treatment Protocol for Management of Bacterial and Fungal Malignant External Otitis: A Large Cohort in Tehran, Iran. The Annals of Otology, Rhinology, and Laryngology. 2017;126(7):561-567. https://doi.org/10.1177%2F0003489417710473
Handzel O, Halperin D. Necrotizing (malignant) external otitis. American Family Physician. 2003;68(2):309-312.
Kryukov AI, Palchun VT, Luchikhin LA, Gurov AV, Magomedov MM, Ivoilov AYu, Machulin AI, Chumakov PL. Naruzhnye otity. Klinicheskie rekomendatsii. 2014. (In Russ.).
Gurov AV, Yushkina MA, Guseva OA, Muratov DL, Sokolov SS. Topical issues of the clinical course and therapy of otitis externa. Medical Council. 2015;15:56-58. (In Russ.). https://doi.org/10.21518/2079-701X-2015-15-56-58
Mosikhin SB, Reshl LI, Bezbryakov AV, Pokrovskaya EM, Bayazitova LT. Microflora of the ear canal with otitis externa. Prakticheskaya meditsina. 2016;94(2):18-24. (In Russ.).
Krasnozhen VN, Pokrovskaya EM, Bayazitova LT. The species composition and sensitivity of pathogenic microflora responsible for the development of otitis externa diffusa to the components of Polidexa. Vestnik otorinolaringologii. 2018;83(1):65-67. (In Russ.). https://doi.org/10.17116/otorino201883165-67
Bayazitova LT, Tyupkina OF, Chazova TA, et al. The use of bacteriophages for phage therapy and phage prophylaxis of antimicrobial resistant strains of Pseudomonas aeruginosa in patients with otitis externa. Bakteriologiya. 2019;4(3):18-23. (In Russ.). https://doi.org/10.20953/2500-1027-2019-3-18-23
Weber-Dabrowska B, Zimecki M, Kruzel M, Kochanowska I, Lusiak-Szelachowska M. Alternative therapies in antibiotic-resistant infection. Advances in Medical Sciences. 2006;51:242-244.
Kryukov AI, Luchikhin LA, Magomedov MM, Garov EV, Sidorina NG, Karneeva OV, Kirichenko IM, Lavrova AS, Zagorskaya EE, Garova EE. Klinicheskie rekomendatsii «Khronicheskij gnojnyj srednij otit». M.—SPb; 2014. (In Russ.).
Preobrazhensky NA, Goldman II, Lipkin AI. The problem of conservative treatment of patients with chronic otitis media. Vestnik otorinolaringologii. 1982;2:18-20. (In Russ.).
Krivokhatskaya LD, Chemerkin AS. On the possibility of increasing the bacteriolytic activity of Pseudomonas aeruginosa bacteriophage in chronic otitis media. Zhurnal ushnykh, nosovykh i gorlovykh boleznej. 1984;5:55-58. (In Russ.).
Volosevich LL, Krivokhatskaya LD, Chemerkin AS. The effectiveness of the use of therapeutic bacteriophages in patients with chronic purulent mesotympanitis. Zhurnal ushnykh, nosovykh i gorlovykh boleznej. 1985;3:55-59. (In Russ.).
Bogovazova GG, Voroshilova NN, Bondarenko VM, Gorbatkova GA, Afanasieva EV, Kazakova TB, Smirnov VD, Mamleeva AG, Glukharev IA, Erastova EI, Krylov IA, Ovcharenko TM, Baturo AP, Yatsyk GV, Arefieva NA. Immunobiological properties and therapeutic efficacy of Klebsiella bacteriophage preparations. Zhurnal mikrobiologii, epidemiologii i immunobiologii. 1992;69(3):30-33. (In Russ.).
Garov EV, Garova EE. Modern principles of diagnosis and treatment of patients with chronic suppurative otitis media. RMZh. 2012;20(27):1355-1359. (In Russ.).
Palchun VT, Kryukov AI. Otorinolaringologiya. Rukovodstvo dlya vrachej. M.: Medicina; 2001. (In Russ.).
Ivoilov AYu. Diagnostic algorithm and treatment tactics for chronic suppurative otitis media in childhood. RMZh. 2011;6:394-397. (In Russ.).
Wright A, Hawkins CH, Anggård EE, Harper DR. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clinical Otolaryngology. 2009;34(4):349-357. https://doi.org/10.1111/j.1749-4486.2009.01973
Kurabi A, Beasley KA, Chang L, McCann J, Pak K, Ryan AF. Peptides actively transported across the tympanic membrane: Functional and structural properties. PLoS One. 2017;12(2):e0172158. https://doi.org/10.1371/journal.pone.0172158
Kurabi A, Cooper M, Spriggs M, Xu Y, Schaerer D, Ryan AF. Molecular Screening Strategy to Identify a Non-invasive Delivery Mechanism for the Treatment of Middle Ear Disorders. Frontiers in Medicine. 2020;7:503819. https://doi.org/10.3389/fmed.2020.503819